Amicus Therapeutics, Inc. (FOLD): Price and Financial Metrics
Amicus Therapeutics, Inc. (FOLD)
Today's Latest Price: $23.18 USD
Updated Dec 4 4:00pm
Add FOLD to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
FOLD Stock Summary
- FOLD's price/sales ratio is 24.65; that's higher than the P/S ratio of 92.56% of US stocks.
- With a year-over-year growth in debt of 114.6%, Amicus Therapeutics Inc's debt growth rate surpasses 89.35% of about US stocks.
- Revenue growth over the past 12 months for Amicus Therapeutics Inc comes in at 53.9%, a number that bests 90.35% of the US stocks we're tracking.
- Stocks that are quantitatively similar to FOLD, based on their financial statements, market capitalization, and price volatility, are PTCT, FPRX, RMBS, XLRN, and MGEN.
- Visit FOLD's SEC page to see the company's official filings. To visit the company's web site, go to www.amicusrx.com.
FOLD Stock Price Chart Interactive Chart >
FOLD Price/Volume Stats
| Current price | $23.18 | 52-week high | $23.60 |
| Prev. close | $21.88 | 52-week low | $6.25 |
| Day low | $22.00 | Volume | 3,119,100 |
| Day high | $23.33 | Avg. volume | 2,774,791 |
| 50-day MA | $18.88 | Dividend yield | N/A |
| 200-day MA | $14.16 | Market Cap | 6.04B |
Amicus Therapeutics, Inc. (FOLD) Company Bio
Amicus Therapeutics is developing treatments for a broad range of human genetic diseases, with a focus on delivering new benefits to individuals with lysosomal storage disorders. The company was founded in 2002 and is based in Cranbury, New Jersey.
Loading social stream, please wait...